Polaris has ongoing collaborations with many organizations.

Through these collaborations, Polaris is able to capitalize on cutting edge advancements taking place in both academia and clinical centers.

Polaris is working with these institutions to identify cancer types in addition to HCC and metastatic melanoma that may benefit from ADI-PEG 20 treatment, and also to identify other therapies to be used in combination with ADI-PEG 20.

Name Institution Area of Study
Dr. Richard Bold University of California, Davis, CA Pancreatic cancer
Dr. John DiPersio & Dr. Mark Schroeder Washington University in St. Louis, MO Acute Myeloid Leukemia
Dr. Richard Gorlick Albert Einstein Medical School, New York, NY Osteosarcoma
Dr. Donna Hansel University of California, San Diego School of Medicine Bladder cancer
Dr. Thai Ho Mayo Clinic, Scottsdale, AZ Renal cell carcinoma
Dr. Hsing-Jien Kung University of California, Davis, CA ADI, Autophagy and Apoptosis, Pancreatic cancer, Prostate cancer
Dr. Macus Tien Kuo MD Anderson Medical Center, Houston, TX Melanoma
Dr. Chien-Feng Li Chi-Mei Medical Center, Tainan, Taiwan Myxofibrosarcoma
Dr. Juan Marini Baylor University, Houston, TX Nutrition, bowel function
Dr. Patrick Maxwell Cambridge University, UK Hypoxia and cancer
Dr. Markus Munder Univesity of Mainz, Germany Neutrophil function
Dr. Gerd Ritter &
Dr. Achim Jungbluth
Ludwig Institute for Cancer Research, branch at Memorial Sloan-Kettering Cancer Center Melanoma, Small Cell Lung cancer
Dr. Sandra Orsulic Cedars-Sinai Medical Center, Los Angeles, CA Ovarian cancer
Dr. Carlos Rodriguez UC Davis School of Veterinary Medicine, Davis, CA Canine cancers
Dr. Brian Rubin Cleveland Clinic, OH Sarcoma
Dr. Niramol Savaraj &
Dr. Lynn Feun
University of Miami Sylvester Comprehensive Cancer Center and Miami VA Medical Center Melanoma
Dr. Lars Stelter Charité University of Medicine, Berlin, Germany Nuclear medicine, Melanoma
Dr. Nelofer Syed Imperial College, London, UK Glioma
Dr. Peter Szlosarek Barts and the London School of Medicine and Dentistry, UK Bladder cancer, Myeloid Leukemia, Lymphoma, Mesothelioma,
Ovarian carcinoma
Dr. Brian Van Tine Washington University in St. Louis, MO Sarcoma